Krebs Biochemicals & Industries Limited (BOM:524518)
India
· Delayed Price · Currency is INR 75.85
+2.85 (3.90%)
At close: May 7, 2025
BOM:524518 Revenue
Krebs Biochemicals & Industries had revenue of 114.67M INR in the quarter ending December 31, 2024, a decrease of -11.64%. This brings the company's revenue in the last twelve months to 491.84M, down -1.45% year-over-year. In the fiscal year ending March 31, 2024, Krebs Biochemicals & Industries had annual revenue of 504.22M, down -3.29%.
Revenue (ttm)
491.84M
Revenue Growth
-1.45%
P/S Ratio
3.24
Revenue / Employee
2.58M
Employees
191
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 504.22M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | 526.84M | 202.88M | 62.63% |
| Mar 31, 2020 | 323.95M | -143.46M | -30.69% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |
Krebs Biochemicals & Industries News
- 3 months ago - Krebs Biochemicals & Industries halts production following order from Andhra Pradesh Pollution Control Board - Business Upturn